The US Food and Drug Administration has released draft guidance on protocol deviations, but experts say it could go further.

The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or ...

The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

MONDAY, Jan. 27, 2025 (HealthDay News) -- Reports of cats becoming seriously ill or dying after consuming raw pet food or ...

Liberty-based Vitti Labs, a human tissue bank, is suing the Food and Drug Administration over how the agency is regulating a ...

Robert F. Kennedy Jr. vows to finalize regulations for greater diverse patient involvement in clinical trials during his ...

If you ask Robert F. Kennedy Jr., Americans are incredibly unhealthy—and he’s on a mission to Make America Healthy Again (MAHA). He first began campaigning as an independent presidential ...

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

The Food and Drug Administration announced last week that it will revoke authorization for FD&C Red No. 3 in food and ...

A proposal to ban formaldehyde in hair straightening products is now in limbo after President Donald Trump signed an ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...